Medical technology companies face a difficult balancing act. They must develop better devices, navigate regulatory requirements, secure investment, and ensure innovations reach patients. As AI and digital health reshape the sector, success increasingly depends on how well companies connect technical innovation with commercial realities and healthcare needs.
The MedTech Conference 2026, hosted by AdvaMed, takes place from October 18–21 in Boston, Massachusetts. The event will bring together more than 4,000 leaders from over 1,800 companies and 40+ countries to discuss the technologies, business decisions, and policies influencing the global medtech industry.
AI, Commercial Growth and Access to Care
Artificial intelligence and digital health feature prominently on the agenda. Discussions will explore emerging applications, including AI agents in medtech, alongside questions about implementation, governance, and the practical value these technologies can deliver.
Investment and commercialization form another major theme. Sessions will examine capital markets, mergers and acquisitions, strategic partnerships, and the challenges of taking emerging technologies from development to market. The expanded investor programming developed with Bank of America will create further opportunities for companies, investors, and potential partners to discuss growth.
Also Read: SEMA Show 2026: Automotive Innovation Returns to Las Vegas, 3-6 November
The agenda also tackles issues that directly affect patient access. Regulatory changes, reimbursement models, manufacturing quality, and supply chain resilience can determine whether a promising medical technology reaches the people who need it. By bringing these subjects together, the conference connects innovation with the business and policy decisions required to advance healthcare.
The Medtech Campus adds a practical dimension through company presentations, technology demonstrations, startup showcases, and one-to-one networking opportunities.
Industry Leaders on the Agenda
The confirmed program features Kevin Lobo of Stryker and Lisa Earnhardt of Abbott in a discussion on how the shift towards ambulatory surgery centers is changing the medtech market.
The CEO panel Pulse on Medtech: The Best Opportunities in Medtech for 2026–2027 will also feature Michael Mahoney of Boston Scientific and Mick Farrell of ResMed, alongside other industry and investment leaders. The session will examine where the sector’s next opportunities for growth and value creation may emerge.
Explore the full 2026 schedule and speaker details here.
For medtech executives, investors, and digital health leaders, the conference offers a view of how technology, regulation, capital, and healthcare delivery intersect to shape the industry’s next phase.
To know more about the event and check waitlist availability, visit The MedTech Conference’s official website.
